Major histocompatibility complex controls clonal proliferation of CD5+ B cells in H-2-congenic New Zealand mice: a model for B cell chronic lymphocytic leukemia and autoimmune disease
- 1 November 1991
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 21 (11), 2743-2748
- https://doi.org/10.1002/eji.1830211114
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Probing the Human B-Cell Repertoire with EBV: Polyreactive Antibodies and CD5+ B LymphocytesAnnual Review of Immunology, 1989
- Ly-1 as a Differentiation Antigen on Normal and Neoplastic B CellsPublished by Springer Science and Business Media LLC ,1984
- The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice.The Journal of Experimental Medicine, 1983
- Genetic Factors Predisposing to Chronic Lymphocytic Leukemia and to Autoimmune Disease1Medicine, 1980
- S.L.E. AND LYMPHOMAThe Lancet, 1979
- Evidence That the Malignant Lymphoma of Sjögren's Syndrome Is a Monoclonal B-Cell NeoplasmNew England Journal of Medicine, 1978
- SYSTEMIC LUPUS ERYTHEMATOSUS AND LYMPHOMAThe Lancet, 1978
- MONOCLONAL MACROGLOBULINEMIA IN NZB/NZW F1 MICEThe Journal of Experimental Medicine, 1973
- Immunopathology and Neoplasms in New Zealand Black (NZB) and SJL/J MicePublished by S. Karger AG ,1969
- The Immunology and Pathology of NZB MiceAdvances in Immunology, 1968